C07K 1/08
Using activating agents
Official title: using activating agents {(C07K1/003, C07K1/006 take precedence)}
C07K1/08 (Using activating agents) appears on 140 US grants and 130 published applications in this corpus.
Search patents in C07K- Granted patents
- 140
- Published applications
- 130
- Assignees
- 124
- Inventors
- 352
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 5 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 5 | 0 |
| 1998 | 7 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 5 | 1 |
| 2002 | 0 | 4 |
| 2003 | 3 | 3 |
| 2004 | 2 | 5 |
| 2005 | 2 | 5 |
| 2006 | 5 | 1 |
| 2007 | 1 | 1 |
| 2008 | 1 | 2 |
| 2009 | 0 | 4 |
| 2010 | 2 | 5 |
| 2011 | 3 | 2 |
| 2012 | 2 | 2 |
| 2013 | 5 | 4 |
| 2014 | 1 | 4 |
| 2015 | 7 | 3 |
| 2016 | 3 | 6 |
| 2017 | 3 | 11 |
| 2018 | 7 | 6 |
| 2019 | 6 | 8 |
| 2020 | 4 | 7 |
| 2021 | 6 | 9 |
| 2022 | 4 | 9 |
| 2023 | 4 | 6 |
| 2024 | 5 | 10 |
| 2025 | 2 | 9 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions of hybrid supported lipid bilayers and methods for producing24 Mar 2026US 12,583,885 B2Cornell University
- Method for producing peptide compound20 Jan 2026US 12,528,834 B2Nissan Chemical Corporation
- Optically verified polymer synthesis26 Aug 2025US 12,398,174 B2The Charles Stark Draper Laboratory, Inc.
- Method for producing peptide compound4 Mar 2025US 12,240,871 B2Nissan Chemical Corporation
- Methods and compositions for live cell analysis of intracellular ATP3 Dec 2024US 12,158,470 B2Sartorius BioAnalytical Instruments, Inc.
- Process of making abaloparatide20 Aug 2026US 2026/0240957 A1Radius Health, Inc.
- Process for the preparation of fmoc-gly-thr [psi (me, me) pro]-oh18 Jun 2026US 2026/0167668 A1Divi’s Laboratories Ltd.
- Dipropylamine as base for the use in fmoc deprotection in solid-phase peptide synthesis12 Feb 2026US 2026/0042795 A1UniversitäT Bern
- Formation of amidines4 Dec 2025US 2025/0368679 A1
- Protein modifying reagent27 Nov 2025US 2025/0361264 A1Canon Kabushiki Kaisha
Most cited
By later US patents
- Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof277US 5,549,974 AAffymax Technologies N.V. · 1996
- Photolabile compounds and methods for their use151US 5,739,386 AAffymax Technologies N.V. · 1998
- Reagants and methods for immobilized polymer synthesis and display92US 5,679,773 AAffymax Technologies N.V. · 1997
- Methods and compositions for controlled polypeptide synthesis75US 6,686,446 B2The Regents of the University of California · 2004
- Methods and compositions for controlled polypeptide synthesis74US 6,632,922 B1The Regents of the University of California · 2003